Clinical Trial Update: Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and GM-CSF in Treating Patients With Recurrent, Refractory, or Metastatic Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating laboratory-treated autologous lymphocytes with aldesleukin and GM-CSF for recurrent, refractory, or metastatic non-small cell lung canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Aldesleukin (Proleukin) (aldesleukin)
• Laboratory-treated autologous lymphocytes
• Leukine (sargramostim) (sargramostim)

Snippet

Sponsor: Roger Williams Medical Center | Conditions: Lung Cancer | Phase 1 | Status: TERMINATED